-
-
Call more information
660-596-2224 -
AUTHORS: Benzon, Honorio T. MD et al Anesthesia & Analgesia: June 2019 – Volume 128 – Issue 6 – p 1089-1096 BACKGROUND: Patients presenting for surgery may have isolated or combined prolonged activated partial thromboplastin time (aPTT) and/or prothrombin time (PT). In patients not receiving anticoagulants or with no identifiable cause for abnormal clot formation, a […]
Read MoreI thought this was interesting so I wanted to share it with our readers. By Mark Terry BioSpace In 1992, the U.S. Food and Drug Administration (FDA) developed its Accelerated Approval Program. It was designed to move certain new drugs to the market faster. The Accelerated Approval leans on a surrogate endpoint, which is a marker, such as […]
Read MoreAuthor: Tauren Dyson People with osteoarthritis who take NSAIDs have a 23 percent higher likelihood of developing cardiac disease compared to people without the condition. File Photo by Kzenon/Shutterstock Nonsteroidal anti-inflammatory drugs that treat inflammation and pain raise the risk of congenital heart disease, heart attack and other conditions for people with osteoarthritis, new findings […]
Read MoreAuthor: Ethan Covey Anesthesiology News Preoperative anxiety, measured using the modified Yale Preoperative Anxiety Scale (mYPAS), can predict rates of emergence delirium, according to a new study. “This study is important because early identification of these at-risk patients can alert the anesthesiologist to appropriately and preemptively medicate patients,” said Ali Atoot, a fourth-year medical student […]
Read MoreAUTHORS: Grabitz, Stephanie D. MD et al Anesthesia & Analgesia: June 2019 – Volume 128 – Issue 6 – p 1129-1136 BACKGROUND: Postoperative residual neuromuscular blockade continues to be a frequent occurrence with a reported incidence rate of up to 64%. However, the effect of postoperative residual neuromuscular blockade on health care utilization remains unclear. We […]
Read More